Weight Watchers reports enhanced weight loss with GLP-1 medication support
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/1/2026
- Wall St futures slip as second half of year begins with Mideast worries
- Oil falls over 1% as markets await outcome of Iran-US talks, US stocks data
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Dollar firm at 1-year highs as Euro Inflation cools; yen in Intervention zone
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- DISH DBS files prepackaged chapter 11 to repay debt, wind down wireless
- Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Boeing commercial jet deliveries and production disrupted by widespread IT outage - Air Current
Weight Watchers Report Finds Integrated GLP-1 Support Drives Significantly Greater Weight Loss Than Medication Alone
March 11, 2026 9:00 AM EDTWeight Watchers Med+ members who regularly engaged with their GLP-1 Success Program lost up to 61% more body weight in the first month and 29% more in one year, on average, than those who took medication alone.
Med+ members prescribed medication also reported, on average, over 30% more weight loss than select competitors at 12 months.
NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (Weight Watchers), the global leader in science-backed weight health, today released a... More
